Open AccessS931 Initial 8-week Therapy with Tofacitinib in Moderate-to-Severe Ulcerative Colitis in a Real World Prospective Multicenter Study (TOUR)
Author(s) -
Millie D. Long,
Anita Afzali,
Monika Fisher,
Emily English,
Xian Zhang,
David Hudesman,
Maisa Abdalla,
Robert P. McCabe,
Benjamin Cohen,
William R. Harlan,
John S. Hanson,
Gauree G. Konijeti,
Steven Polyak,
Timothy E. Ritter,
Bruce Salzberg,
Hans Herfarth
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000777256.07149.aa
Subject(s) - tofacitinib , medicine , ulcerative colitis , adverse effect , janus kinase inhibitor , inflammatory bowel disease , gastroenterology , disease , rheumatoid arthritis